Overview of Cancer Stem Cells and Stemness for Community Oncologists Justin D. LathiaHuiping Liu Review Article Open access 30 June 2017 Pages: 387 - 399
Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet Daniel P. PetrylakE. David Crawford Review Article 16 June 2017 Pages: 401 - 412
Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock? Maximilian StahlBenjamin Y. LuAmer M. Zeidan Review Article 29 June 2017 Pages: 413 - 447
Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma Monica BartucciMohamed S. HusseinHatem E. Sabaawy Original Research Article 06 June 2017 Pages: 449 - 462
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer Michael MichaelYung-Jue BangJeanne Tie Original Research Article 06 June 2017 Pages: 463 - 474
Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study Maya GottfriedJaafar BennounaMartin Reck Original Research Article 12 July 2017 Pages: 475 - 485
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy Solène-Florence Kammerer-JacquetSarah MedaneNathalie Rioux-Leclercq Original Research Article 26 May 2017 Pages: 487 - 494
Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab Anna KukMagdalena MagnowskaEwa Nowak-Markwitz Original Research Article Open access 04 June 2017 Pages: 495 - 503
Prolonged Overall Treatment Time and Lack of Skin Rash Negatively Impact Overall Survival in Locally Advanced Head and Neck Cancer Patients Treated with Radiotherapy and Concomitant Cetuximab Julien RomanGurvan DissauxUlrike Schick Original Research Article 03 June 2017 Pages: 505 - 512
Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP) Andrés F. CardonaOscar Arrietaon behalf of CLICaP Original Research Article 15 June 2017 Pages: 513 - 523
Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience Andrea Sartore-BianchiAlessio AmatuSalvatore Siena Original Research Article Open access 01 July 2017 Pages: 525 - 533
Ixazomib: A Review in Relapsed and/or Refractory Multiple Myeloma Zaina T. Al-SalamaKarly P. Garnock-JonesLesley J. Scott Adis Drug Evaluation 28 June 2017 Pages: 535 - 542
Pazopanib: a Review in Advanced Renal Cell Carcinoma James E. Frampton Adis Drug Evaluation 29 June 2017 Pages: 543 - 554
Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer Yvette N. LambLesley J. Scott Adis Drug Evaluation 14 July 2017 Pages: 555 - 562